ID   GHOST(3).CXCR6
AC   CVCL_S493
SY   GHOST (3) Bonzo/STRL33; GHOST cell BONZO/STRL33; GHOST (3) Bonzo+
DR   BEI_Resources; ARP-3687
DR   cancercelllines; CVCL_S493
DR   Wikidata; Q54835793
RX   PubMed=16061987;
WW   Provider; NIBSC; 0081; http://www.nibsc.org/Default.aspx?pageid=597&ID=0081
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16647; CXCR6.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
RX   PubMed=16061987; DOI=10.1385/1-59259-907-9:333;
RA   Vodros, Dalma
RA   Fenyo, Eva-Maria
RT   "Quantitative evaluation of HIV and SIV co-receptor use with GHOST(3)
RT   cell assay.";
RL   Methods Mol. Biol. 304:333-342(2005).
//